Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer SurvivalJuan José Lahuerta, Jesús F. San Miguel, María‐Victoria Mateos et al.|Journal of Clinical Oncology|2008Cited by 282
Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 casesRamón García‐Sánz, Jesús F. San Miguel, Silvia Montoto et al.|British Journal of Haematology|2001Cited by 267
Long-term prognostic significance of response in multiple myeloma after stem cell transplantationJoaquín Martínez‐López, Joan Bladé, María‐Victoria Mateos et al.|Blood|2011Cited by 210
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?Jesús F. San Miguel, J Díaz-Mediavilla, Juan José Lahuerta et al.|The Hematology Journal|2000Cited by 117
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyJuan José Lahuerta, M.V. Mateos, Joaquín Martínez‐López et al.|Haematologica|2010Cited by 113